HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 08, August 2017 – Eye – the Window to your Soul       » Palm-Sized PCR Device for Rapid Real-Time Detection of Viruses       » Scientists Uncover New Mechanism for Diabetic Neuropathy       » China Enlists AI to Diagnose Breast Cancer       » Philips and Singapore Institute of Advanced Medicine Holdings Sign Agreement to Open First-of-its-kind Oncology Center in Singapore       » Guardian Partners with MyDoc to Address Singapore's Population Health Needs through Integrating Technology and Self-Care       » Database Boosts Shanghai's Technology Aim      
EYE ON CHINA
Nobel Laureate Cooperates with Infinitus to Explore the Potential Roles of TCM in Immune Regulation

GUANGZHOU, China — On 6 March 2017, Infinitus (China) Company Limited, a member of LKK Health Products Group ("LKKHPG"), signed a letter of intent with Professor Jules A. Hoffmann, the Nobel laureate in physiology or medicine, in respect of his acting as the consultant of Infinitus. The signing ceremony was held at Infinitus R&D Center in Guangzhou. Infinitus will establish a long-term strategic partnership with Professor Hoffmann and his colleagues from their CNRS (National Center for Scientific Research) laboratory in Strasbourg, France, and will carry out in-depth cooperation in their well-established innate immune model systems to expand the understanding of Traditional Chinese Medicine ("TCM"), namely the anti-virus activities and gut immunity and etc., of TCM and to favor the application of basic research to Chinese herbal health products.

Professor Hoffmann has dedicated his life to the study of innate immunity. Recognized as a pioneer in this field, he has been elected to the national academies of sciences from many countries, including USA, France, Germany and Russia. He and his associates have discovered the role of the Toll transmembrane receptor, in sensing pathogenic micro-organisms. The discovery of this key principle has provided the bases for understanding the activation of the adaptive immune response by innate immunity and has opened new paths in the prevention and treatment of major immunity related diseases.

Professor Hoffmann commented on the partnership and said: "the efficacy of Chinese herbal medicine is getting more attention these days. Its important role in immune regulation has become a global academic interest, which warrants the development of basic research in this area. Given the significant achievements and the solid strength in its R&D, Infinitus appears as an ideal partner for such undertakings."

Infinitus has been dedicated to providing the public with high-quality Chinese herbal health products and services for over 20 years. Early in 1994, Infinitus brought into market its first compound polysaccharide product, Infinitus Health Tonic, which acts on regulating the human immunity and has leading market shares in China now. In addition, Infinitus has cooperated with Guangzhou University of Chinese Medicine, Chinese Academy of Sciences Shanghai Institute of Materia Medica and other authoritative institutions for the immunity research of Chinese herbal medicine compound polysaccharide. In 2012, Infinitus launched the Polysac™ compound polysaccharide, which attained patents from both China and America, and further strengthened its position in the immunity research of Chinese herbal medicine.

Mr. Harry Yeung, Senior Vice President of LKKHPG said: "With Nobel laureate's achievements in immunity system and Infinitus' experience in TCM research, the cooperation will further strengthen Infinitus' R&D capability on immune regulation with TCM, from which consumers will benefit via high-quality Chinese herbal health products with more remarkable effects." Learn more at
www.lkkhpg.com

Source: LKK Health Products Group &
PR Newswire

Click here for the complete issue.

NEWS CRUNCH  
news Vitafoods Asia 2017 heralds a new future of innovation
news Sanner receives Zero Defect Award
news AdAlta pioneers novel drug for rare lung disease
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Emerging Infectious Diseases
October:
No. 1 Killer — Heart Diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy